Zobrazeno 1 - 10
of 3 398
pro vyhledávání: '"HTA"'
Autor:
Al Rashdi, Ibrahim, Al Balushi, Sara, Al Shuaili, Alia, Al Rashdi, Said, Ibrahim Al Bulushi, Nadiya, Ibrahim Al Kindi, Asiya, Al Salmi, Qasem, Al Sabti, Hilal, Korra, Nada, Abaza, Sherif, Fasseeh, Ahmad Nader, Kaló, Zoltán
Publikováno v:
Journal of Health Organization and Management, 2024, Vol. 38, Issue 9, pp. 241-257.
Externí odkaz:
http://www.emeraldinsight.com/doi/10.1108/JHOM-01-2024-0012
Autor:
Volker Schuster
Publikováno v:
Journal of Market Access & Health Policy, Vol 12, Iss 2, Pp 100-104 (2024)
The vision of a unified European HTA is by no means a new endeavor. At its core are the publicly declared ambitions to harmonize assessments of clinical data within the EU and avoid the duplication of efforts. Not surprisingly, these ambitions are pu
Externí odkaz:
https://doaj.org/article/df64e9692b3942b6a7ba830f6167d14a
Autor:
Grammati Sarri, Luis G Hernandez
Publikováno v:
Journal of Comparative Effectiveness Research, Vol 13, Iss 9 (2024)
Aim: Regulatory and health technology assessment (HTA) agencies have increasingly published frameworks, guidelines, and recommendations for the use of real-world evidence (RWE) in healthcare decision-making. Variations in the scope and content of t
Externí odkaz:
https://doaj.org/article/416f01a1616a49fd890b1718bf7c24b7
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Externí odkaz:
https://doaj.org/article/4c0a59d213b74c51b07703870f1043e5
Autor:
Sreeram V Ramagopalan, Manuel Gomes, Isabelle Durand-Zaleski, Bill Malcolm, Jose Diaz, Grace Mitchell, Jonathan Pearson-Stuttard, Louis P Garrison Jr
Publikováno v:
Journal of Comparative Effectiveness Research, Vol 13, Iss 9 (2024)
Externí odkaz:
https://doaj.org/article/f24885864e734f09994c94a4839754e2
Publikováno v:
Journal of Comparative Effectiveness Research, Vol 13, Iss 9 (2024)
Externí odkaz:
https://doaj.org/article/ac535fd87a54473fab495d3a02b33586
Autor:
Massimo Crapis, Sergio Venturini, Astrid Callegari, Giovanni Del Fabro, Igor Bramuzzo, Laura De Santi, Elisa Pontoni, Maurizio Tonizzo, Barbara Basso
Publikováno v:
Global & Regional Health Technology Assessment, Vol 11, Iss Suppl. 2 (2024)
Introduction: Dalbavancin is a semisynthetic lipoglycopeptide long-acting antibiotic approved for the treatment of acute bacterial skin and skin structure infections (ABSSSIs). Its features can be useful in the current healthcare scenario characteriz
Externí odkaz:
https://doaj.org/article/a1d8b680171246b58bb40c4e74923b3e
Autor:
Mariano Zalis, Gilson Gabriel Viana Veloso, Pedro Nazareth Aguiar Jr., Nathalia Gimenes, Marina Xavier Reis, Silvio Matsas, Carlos Gil Ferreira
Publikováno v:
Frontiers in Genetics, Vol 15 (2024)
Fundamentally precision oncology illustrates the path in which molecular profiling of tumors can illuminate their biological behavior, diversity, and likely outcomes by identifying distinct genetic mutations, protein levels, and other biomarkers that
Externí odkaz:
https://doaj.org/article/6ccfcb1cf470465abaf8918611325314
Autor:
Julia Bidonde, Vigdis Lauvrak, Aparna Ananthakrishnan, Pritaporn Kingkaew, Elizabeth F. Peacocke
Publikováno v:
Cost Effectiveness and Resource Allocation, Vol 22, Iss 1, Pp 1-16 (2024)
Abstract Background There is limited evidence-informed guidance on TISP processes for countries where health technology assessment (HTA) is in a nascent phase. We aimed to explore the range of topic identification, selection and prioritization (TISP)
Externí odkaz:
https://doaj.org/article/a70e4e33ebe940fe8e376512f0d54b87
Autor:
Alkiviadis Vatopoulos
Publikováno v:
Frontiers in Antibiotics, Vol 3 (2024)
Clinical Microbiology has developed during the last 100 years, simultaneous with the discovery of microorganisms as causes of infections. Globalization and One Health determine present needs whereas molecular biology, automation, artificial intellige
Externí odkaz:
https://doaj.org/article/93f2e3d774724f47ad6a85773d542231